TrialClinIQ | $150,000 | (Apr 29, 2026)
Lighthouse Pharmaceuticals | $12,000,000 | (Apr 29, 2026)
Windmill(US) | $12,000,000 | (Apr 29, 2026)
Certified by Founder
Lodge
Keen Venture Partners
investor
Netherlands
- Amsterdam, North Holland
- 09/11/2022
- Series C
- $50,000,000
Keen Venture Partners is a radically human venture capital firm that backs exceptional founders across Europe from Seed to Series B.
- Industry Venture Capital and Private Equity Principals
- Website https://www.keenventurepartners.com/
- LinkedIn https://www.linkedin.com/company/keen-venture-partners/
IC Realtime | $2,000,000 | (Apr 29, 2026)
Golden Child | $37,000,000 | (Apr 29, 2026)
Hypervision Surgical | $22,962,410 | (Apr 29, 2026)
dehaze | $3,746,192 | (Apr 29, 2026)
Clarasight | $11,500,000 | (Apr 29, 2026)
Liquid Instruments | $50,000,000 | (Apr 29, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)